Skip to content

Article: Nicotinamide Riboside Alters Gut Microbiota to Reduce Weight Gain from High-Fat Diet in Mice: Preclinical Findings

Nicotinamide Riboside Alters Gut Microbiota to Reduce Weight Gain from High-Fat Diet in Mice: Preclinical Findings


Synopsis

The gut microbiome influences energy balance and obesity risk. Nicotinamide riboside (NR), a vitamin B3 form and NAD+ precursor, can reduce weight gain and increase energy use in obese mice. This study tested whether changes in gut bacteria contribute to NR's effects. Mice given NR had altered gut microbes, with more butyrate-producing bacteria linked to energy metabolism. Transferring feces from NR-treated mice to other obese mice reduced weight gain and boosted energy use. These findings suggest NR benefits partly come from changes in gut bacteria, which might enhance NR's therapeutic effects against obesity and related diseases.

Journal

mSystems

Read more

Autoimmune Disease

Nicotinamide Riboside Supplementation Boosts NAD+ and Lowers Inflammatory Immune Signaling in Lupus: Clinical Findings

Objectives To explore the anti-inflammatory effects of NR in monocytes (a type of white blood cell; immune cell) extracted from young, healthy subjects following supplementation. Additionally, the...

Read more
Neurological Health

Nicotinamide Riboside Reduces Chemotherapy-Induced Eye and Body Hypersensitivity: Preclinical Findings

SynopsisChemotherapy often causes dry eye and nerve pain, which may be due to nerve damage. This study treated rats given the chemotherapy drug paclitaxel with nicotinamide riboside (NR). Paclitaxe...

Read more